Le Lézard
Classified in: Health
Subject: FDA

Sonavex Receives FDA 510(k) Clearance for EchoSure


BALTIMORE, March 11, 2019 /PRNewswire-PRWeb/ -- Sonavex, Inc., a privately held medical device company focused on empowered patient care, announced today that on March 8, 2019 it received 510(k) clearance from the U.S. Food and Drug Administration for its EchoSure device to deliver definitive blood flow data on demand.

The EchoSure system combines 3D ultrasound imaging with advanced deep learning algorithms to automate visual and quantitative blood flow monitoring after surgery. Coupled with Sonavex's FDA-cleared EchoMark® bioresorbable markers, EchoSure eliminates the need for ultrasound expertise in order to measure blood flow. The EchoSure App enables surgeons to monitor patients remotely from their mobile devices.

"For decades, the surgical community has sought a simple, fast and non-invasive way to accurately quantify blood flow after microvascular and vascular surgeries," said Devin O'Brien Coon, MD, Chief Medical Officer and President of Sonavex and a board-certified plastic and microvascular surgeon at Johns Hopkins. "Putting ultrasound technology in the hands of bedside nurses for the first time may enable detection of vascular compromise earlier than clinical observation alone, providing opportunities for more rapid intervention and improved patient outcomes."

This news follows within months of FDA clearance of Sonavex's EchoMark device. "The Sonavex team worked tirelessly for more than five years to create a solution that enables surgeons and nurses to easily collect vital information in real-time so they can provide the best results for their patients," said David Narrow, CEO of Sonavex. "This is a critical milestone in our mission to bring transformative ultrasound technologies to patients, and we are excited to ramp up commercialization efforts this spring."

EchoMark and EchoSure are both available from Sonavex for clinical use across the United States.

---

About Sonavex, Inc.
Sonavex, Inc. is a Baltimore-based medical device company originally spun out of Johns Hopkins. The company has developed a portfolio of novel ultrasound solutions that empower patient care by delivering critical visual and quantitative data to improve outcomes and reduce costs. For more information, please visit http://www.sonavex.com.

 

SOURCE Sonavex


These press releases may also interest you

at 07:00
Intelligent.com, a trusted resource for online degree rankings and higher education planning, has announced the Top 55 Best Master of Science in Nursing (MSN) Degree Programs for 2020. The comprehensive research guide is based on an assessment of 176...

at 07:00
More than 85 million people across the United States currently suffer from various skin issues according to a recent report from the American Academy of Dermatology, indicating this problem is more common than previously believed. Studies show the...

at 07:00
Intelligent.com Announces Best Nutrition Degree Programs for 2020 Degree holders gain increased earning potential with career opportunities upon graduation from these top ranked institutions. Intelligent.com, a trusted resource for online degree...

at 06:00
Ceribell, Inc announced the launch of Clarity, a new 24/7 bedside EEG monitoring and alerting technology, at the American Epileptology Society Annual Meeting.  Ceribell's Rapid Response EEG system made bedside EEG possible for critically ill patients...

at 06:00
Intelligent.com, a trusted resource for online degree rankings and higher education planning, has announced the Top 25 Doctorate in Psychology Degree Programs for 2020. The comprehensive research guide is based on an assessment of 148 accredited...

at 03:00
On one end of the humility spectrum, there's the braggers. It doesn't matter if all they've done is fry an egg without burning it - the entire world must know of their accomplishments. Next, there's the humble-braggers. They think they're being...



News published on 11 march 2019 at 09:30 and distributed by: